Ras, short for rat sarcoma, belongs to the monomer GTP binding protein with weak GTPase activity. Usually, Ras distributes on the cytoplasmic side of the plasma membrane and is inactive through the binding with GDP.
In the Ras signaling pathway, activated Ras further stimulates the phosphorylation of its substrate proteins, mediating many signaling pathways involved in various vital cellular processes.
The Ras signaling pathway is involved in many important cellular processes such as cell proliferation ＆survival, differentiation, apoptosis, cytoskeletal movement, protein transport ＆ secretion.
Normally, Ras combines with GDP and is in an inactive state. When Ras protein is released from Ras/GDP and binds to GTP, Ras is activated. Guanylate exchange factors (GEFs) (e.g. Sos) are stimuli for the activation of Ras. GAP (GTPase activating proteins) catalyzing the hydrolysis of GTP to GDP in Ras/GTP, deactivating Ras.
GEFs promote the release of GDP from Ras/GDP. Sos cannot bind directly to the receptor due to the lack of the SH2 domain. The adaptor protein Grb2 binds to the phosphotyrosine residue of the receptor via SH2 and then binds to Sos through SH3. Sos subsequently contacts Ras on the membrane to activate Ras. Or Ras is activated through the activation of RPTK by growth factors such as EGF, PDGF, and FGF.
Active Ras binds and activates Raf. Activated Raf phosphorylates and activates MEK1/2. MEK 1/2 phosphorylates ERK1/2 to activate it. Activation of ERK1/2 into the nucleus activates the expression of many downstream genes such as Elk-1, elf-4E to promote cell proliferation and differentiation.
In addition, activated Ras can directly bind and activate PI3K. Activation of PI3K converts PIP2 into PIP3. The second messenger PIP3 further stimulates PDK, which subsequently activates Akt, starting the PI3K-AKt signaling pathway that regulates cell proliferation.
RalGDS stimulates GDP to dissociate from the Ras-related RalA and RalB GTPases, which allows GTP binding and activation of the GTPases. RalBP can inhibit RacGTP and Cdc42 enzymes, and then regulate actin cytoskeleton remodeling and activate transcription factor NF-κβ through Rac/Cdc42. The process promotes the production of anti-apoptotic proteins to inhibit apoptosis.
The most common Ras gene mutation in tumors is the substitution of the 12th and 13th glycine or the 61st glutamine by other amino acid residues. AP is unable to hydrolyze GTP in mutant RAS. Without the help of GAP, the hydrolysis of GTP will be completely dependent on the GTPase of RAS itself, so the hydrolysis will last longer. This means that Ras/GTP cannot become Ras/GDP and is in a GTP-bound state for a long time, which causes excessive activation of the Ras-Raf-MEK-ERK pathway, resulting in excessive cell proliferation and tumorigenesis.
|PLA2G12A||PLA2G12A Antibody||PLA2G12A Protein||PLA2G12A cDNA||PLA2G12A ELISA Kit|
|PLA2G12B||PLA2G12B Antibody||PLA2G12B Protein||PLA2G12B cDNA||PLA2G12B ELISA Kit|
|PLA2G16||PLA2G16 Antibody||PLA2G16 Protein||PLA2G16 cDNA||PLA2G16 ELISA Kit|
|PLA2G1B||PLA2G1B Antibody||PLA2G1B Protein||PLA2G1B cDNA||PLA2G1B ELISA Kit|
|PLA2G2A||PLA2G2A Antibody||PLA2G2A Protein||PLA2G2A cDNA||PLA2G2A ELISA Kit|
|PLA2G2D||PLA2G2D Antibody||PLA2G2D Protein||PLA2G2D cDNA||PLA2G2D ELISA Kit|
|PLA2G2E||PLA2G2E Antibody||PLA2G2E Protein||PLA2G2E cDNA||PLA2G2E ELISA Kit|
|PLA2G2F||PLA2G2F Antibody||PLA2G2F Protein||PLA2G2F cDNA||PLA2G2F ELISA Kit|
|PLA2G3||PLA2G3 Antibody||PLA2G3 Protein||PLA2G3 cDNA||PLA2G3 ELISA Kit|
|PLA2G4A||PLA2G4A Antibody||PLA2G4A Protein||PLA2G4A cDNA||PLA2G4A ELISA Kit|
|PLA2G4C||PLA2G4C Antibody||PLA2G4C Protein||PLA2G4C cDNA||PLA2G4C ELISA Kit|
|PLA2G4D||PLA2G4D Antibody||PLA2G4D Protein||PLA2G4D cDNA||PLA2G4D ELISA Kit|
|PLA2G4E||PLA2G4E Antibody||PLA2G4E Protein||PLA2G4E cDNA||PLA2G4E ELISA Kit|
|PLA2G4F||PLA2G4F Antibody||PLA2G4F Protein||PLA2G4F cDNA||PLA2G4F ELISA Kit|
|PLA2G5||PLA2G5 Antibody||PLA2G5 Protein||PLA2G5 cDNA||PLA2G5 ELISA Kit|
|PLA2G6||PLA2G6 Antibody||PLA2G6 Protein||PLA2G6 cDNA||PLA2G6 ELISA Kit|
|PLCE1||PLCE1 Antibody||PLCE1 Protein||PLCE1 cDNA||PLCE1 ELISA Kit|
|PLCG1||PLCG1 Antibody||PLCG1 Protein||PLCG1 cDNA||PLCG1 ELISA Kit|
|PLCG2||PLCG2 Antibody||PLCG2 Protein||PLCG2 cDNA||PLCG2 ELISA Kit|
|PLD1||PLD1 Antibody||PLD1 Protein||PLD1 cDNA||PLD1 ELISA Kit|